CHIMERA INVESTMENT CORP
For the period ended Jun 30, 2026. Filed Aug 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 5, 2026
CIM$7.28-0.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
(Unaudited) and
| CHIMERA INVESTMENT CORPORATION | ||
|---|---|---|
| CONSOLIDATED STATEMENTS OF CASH FLOWS | ||
| (dollars in thousands) | ||
| (Unaudited) | ||
| For the Six Months Ended | ||
| June 30, 2026 | June 30, 2025 | |
| Cash Flows From Operating Activities: | ||
| Net income (loss) | $(26,541) | $202,747 |
| Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities: | ||
| (Accretion) Amortization of investment discounts/premiums, net | (17,079) | 522 |
| Accretion of deferred financing costs, debt issuance costs, and Securitized debt discounts/premiums, net | 8,706 | 7,372 |
| Net unrealized (gains) losses on derivatives | (33,548) | 9,024 |
| (Payments) proceeds for derivative settlements | 2,476 | — |
| Margin received (paid) on derivatives | 46,753 | (79,889) |
| Net unrealized (gains) losses on financial instruments at fair value | 80,923 | (135,866) |
| Net realized losses on sales of investments | 50,051 | 1,915 |
| Other investment (gains) losses | (320) | (2,536) |
| Net increase in provision for credit losses | 10,016 | 7,796 |
| Depreciation, amortization, and impairment expense | 13,725 | 1,902 |
| Gain on origination sale, net | (2,803) | — |
| (Gain) loss on extinguishment of debt | 41,605 | (2,122) |
| Equity-based compensation expense | 5,679 | 5,886 |
| Non-cash imputed compensation related to business acquisition | 682 | 682 |
| Originations and purchases of mortgage loans held-for-sale | (2,278,604) | — |
| Sales, settlements and proceeds from sale of loans held-for-sale | 2,045,952 | — |
| Fair value adjustment on mortgage loans held-for-sale | 1,298 | — |
| Changes in operating assets: | ||
| Decrease in accrued interest receivable | 2,276 | 6,775 |
| (Decrease) increase in other assets | (65,540) | 26,861 |
| Changes in operating liabilities: | ||
| Increase (decrease) in accounts payable and other liabilities | 19,802 | (9,301) |
| Decrease in accrued interest payable | (1,411) | (398) |
| Net cash (used in) provided by operating activities | $(95,902) | $41,370 |
| Cash Flows From Investing Activities: | ||
| Agency MBS portfolio: | ||
| Purchases | $(2,324,339) | $(1,921,957) |
| Sales | 138,839 | 127,677 |
| Principal payments | 343,323 | 42,859 |
| Non-Agency RMBS portfolio: | ||
| Purchases | — | — |
| Sales | 13,491 | 12,234 |
| Principal payments | 50,798 | 53,256 |
| Loans held for investment: | ||
| Purchases | (469,382) | (436,482) |
| Sales | 1,657,190 | — |
| Principal payments | 580,881 | 744,254 |
| Distributions received from interests in MSR financing receivables | 7,544 | — |
| Net cash (used in) investing activities | $(1,655) | $(1,378,159) |
| Cash Flows From Financing Activities: | ||
| Proceeds from secured financing agreements | $34,138,967 | $21,680,562 |
| Payments on secured financing agreements | (32,442,926) | (19,950,820) |
| Proceeds from securitized debt borrowings, collateralized by Loans held for investment | 378,755 | 780,166 |
| Payments on securitized debt borrowings, collateralized by Loans held for investment | (1,697,863) | (903,304) |
| Payments on securitized debt borrowings, collateralized by Non-Agency RMBS | (2) | (15) |
| Common dividends paid | (70,017) | (60,792) |
| Preferred dividends paid | (42,478) | (42,783) |
| Net cash provided by (used in) financing activities | $264,436 | $1,503,014 |
| Net increase in cash, cash equivalents and restricted cash | 166,879 | 166,225 |
|---|---|---|
| Cash, cash equivalents and restricted cash at beginning of period | 284,465 | 83,998 |
| Cash, cash equivalents and restricted cash at end of period | $451,344 | $250,223 |
| Supplemental disclosure of cash flow information: | ||
| Interest received | $426,117 | $399,211 |
| Interest paid | 288,114 | 250,007 |
| Change in fair value of contingent earn-out liability | 4,340 | — |
| Non-cash investing activities: | ||
| Payable for investments purchased | $— | $387,909 |
| Net change in unrealized gain (loss) on available-for-sale securities | (17,311) | (7,014) |
| Non-cash financing activities: | ||
| Dividends declared, not yet paid | $41,973 | $34,650 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.